Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

MLA

Naomi K. Tepper, et al. “Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021.” MMWR. Morbidity and Mortality Weekly Report, vol. 70, Aug. 2021, pp. 1094–99. EBSCOhost, https://doi.org/10.15585/mmwr.mm7032e4.

APA

Naomi K. Tepper, John R. Su, Emily Jane Woo, Kevin C. Ess, Veronica V. McNally, Meghna Alimchandani, Danielle Moulia, Lauri E. Markowitz, Tom T. Shimabukuro, Adamma Mba-Jonas, Hannah G. Rosenblum, Kayla E. Hanson, Stephen C. Hadler, H. Keipp Talbot, Melinda Wharton, Jose R. Romero, Sarah Mbaeyi, Narayan Nair, Matthew F. Daley, … Nicola P. Klein. (2021). Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021. MMWR. Morbidity and Mortality Weekly Report, 70, 1094–1099. https://doi.org/10.15585/mmwr.mm7032e4

Chicago

Naomi K. Tepper, John R. Su, Emily Jane Woo, Kevin C. Ess, Veronica V. McNally, Meghna Alimchandani, Danielle Moulia, et al. 2021. “Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021.” MMWR. Morbidity and Mortality Weekly Report 70 (August): 1094–99. doi:10.15585/mmwr.mm7032e4.